Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Koninklijke Philips NV (PHG) vs Vistra Corp (VST) Price & Performance

Koninklijke Philips NVTrade
Vistra CorpTrade

Price performance (Past 24H)

Key statistics

Koninklijke Philips NV vs Vistra Corp — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while Vistra Corp trades at $166.7 (market cap $54.73B). The key difference: Vistra Corp is far larger — about 2.1× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.81%). Which is the better fit depends on your goals.

PHGVST
Market Cap
$25.89B$54.73B
Sector
HealthTechnology
52-Week High
$32.91$217.92
52-Week Low
$25.02$134.71
Enterprise Value
$32.18B$76.49B
Dividend Yield
3.81%0.56%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Koninklijke Philips NV

PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.

The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.

Vistra Corp

Vistra Corp (VST) trades at $157.99, up 1.64% with strong institutional support and bullish technical signals. The stock shows robust fundamentals with 74.92% ROE and 11.52% net margin, though recent earnings were mixed with Q1 2026 beating expectations but Q3 and Q4 2025 missing. Analyst consensus remains overwhelmingly positive with 91% buy ratings and a $253 price target, representing 60% upside potential. Recent news highlights Vistra's positioning in the AI power infrastructure boom and long-term power purchase agreements with major tech companies.

Vistra presents significant growth potential driven by AI infrastructure demand and nuclear energy expansion, but faces risks from power price volatility and high debt levels. The company's diversified utility operations and strategic PPAs provide revenue stability, while technical indicators suggest continued upward momentum with key resistance at $159-$162. Investors should weigh the strong analyst support against execution risks in capital-intensive energy projects.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG

About Vistra Corp

Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.

Read more on VST